Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort

Lupus - Tập 21 Số 8 - Trang 830-835 - 2012
Rohan Willis1, Alan M. Seif1, Gerald McGwin2, L-A Martinez-Martinez1, Emma Camarero González3,1, Neha Dang1, Elizabeth Papalardo1, J. LIU2, LM Vilá4, John D. Reveille5, GS Alarcón2, Silvia S. Pierangeli1
1University of Texas Medical Branch, Galveston, USA
2University of Alabama at Birmingham USA
3Internal Medicine
4University of Puerto Rico Medical Sciences Campus, San Juan, USA
5University of Texas-Houston Health Sciences Center, Houston, USA

Tóm tắt

Objective: We sought to determine the effect of hydroxychloroquine therapy on the levels proinflammatory/prothrombotic markers and disease activity scores in patients with systemic lupus erythematosus (SLE) in a multiethnic, multi-center cohort (LUMINA). Methods: Plasma/serum samples from SLE patients ( n = 35) were evaluated at baseline and after hydroxychloroquine treatment. Disease activity was assessed using SLAM-R scores. Interferon (IFN)-α2, interleukin (IL)-1β, IL-6, IL-8, inducible protein (IP)-10, monocyte chemotactic protein-1, tumor necrosis factor (TNF)-α and soluble CD40 ligand (sCD40L) levels were determined by a multiplex immunoassay. Anticardiolipin antibodies were evaluated using ELISA assays. Thirty-two frequency-matched plasma/serum samples from healthy donors were used as controls. Results: Levels of IL-6, IP-10, sCD40L, IFN-α and TNF-α were significantly elevated in SLE patients versus controls. There was a positive but moderate correlation between SLAM-R scores at baseline and levels of IFN-α ( p = 0.0546). Hydroxychloroquine therapy resulted in a significant decrease in SLAM-R scores ( p = 0.0157), and the decrease in SLAM-R after hydroxychloroquine therapy strongly correlated with decreases in IFN-α ( p = 0.0087). Conclusions: Hydroxychloroquine therapy resulted in significant clinical improvement in SLE patients, which strongly correlated with reductions in IFN-α levels. This indicates an important role for the inhibition of endogenous TLR activation in the action of hydroxychloroquine in SLE and provides additional evidence for the importance of type I interferons in the pathogenesis of SLE. This study underscores the use of hydroxychloroquine in the treatment of SLE.

Từ khóa


Tài liệu tham khảo

10.1016/S0092-8674(00)81108-3

10.1155/2010/676284

10.1073/pnas.0337679100

10.1371/journal.pmed.0030491

10.1002/art.24803

10.1007/s100670050045

10.1172/JCI7014

10.1002/art.20120

10.1002/art.21009

10.4049/jimmunol.174.1.485

10.1191/096120398678919778

10.1002/art.21039

10.1177/0961203306072426

10.1136/ard.2006.068676

Edwards MH, Pierangeli S, Liu X, Barker JH, Anderson G, Harris EN. Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice. Circulation 1997; 96(12): 4380–4384.

10.1177/0961203396005001051

10.1002/art.27289

10.1002/1529-0131(199807)41:7<1161::AID-ART4>3.0.CO;2-K

10.1002/art.1780251101

10.1016/S0002-9343(96)00335-X

10.1191/961203303lu398oa

10.1177/0961203309360985

10.1056/NEJM197907053010102

10.1016/j.rdc.2009.12.008

10.4049/jimmunol.1000702

10.1084/jem.20050914

10.1002/art.24557

10.1002/art.1780400522

Potvin F, 1997, J Immunol, 158, 1872, 10.4049/jimmunol.158.4.1872

10.1182/blood.V95.11.3460

Sperber K, 1993, J Rheumatol, 20, 803

Van den Borne BE, 1997, J Rheumatol, 24, 55

10.1016/0049-3848(94)90270-4

10.1055/s-0037-1613033

10.1182/blood-2008-03-144204

10.1182/blood-2009-04-213520

10.1177/0961203306071872

10.1093/rheumatology/41.8.924

10.1191/0961203305lu2230xx

10.1136/ard.2008.093013

10.1002/art.24232

10.1093/rheumatology/kei014

McCarty GA, Cason TE. Use of hydroxychloroquine in antiphospholipid antibody syndrome at three academic rheumatology units over two years: improvement in antibody titer and symptom management. In: 7th International Congress on SLE and related conditions abstract book 2004; M17A (abstract).

10.1136/ard.2004.031856